MPLN - MultiPlan Corporation
NYSE
->
Healthcare
->
Healthcare Plans
New York,
United States
Type: Equity
MPLN price evolution
MPLN
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $81.49 | $107.61 | $95.89 | $272.24 |
| Short term investments | ||||
| Net receivables | $76.56 | $69.34 | $69.9 | $67.03 |
| Inventory | ||||
| Total current assets | $193.59 | $211.66 | $209.03 | $371.45 |
| Long term investments | ||||
| Property, plant & equipment | $287.11 | $276.91 | $271.35 | $261.83 |
| Goodwill & intangible assets | $6462.21 | $6548.18 | $6634.5 | $6560.27 |
| Total noncurrent assets | $6771.09 | $6846.15 | $6927.36 | $6843.8 |
| Total investments | ||||
| Total assets | $6964.69 | $7057.82 | $7136.39 | $7215.25 |
| Current liabilities | ||||
| Accounts payable | $19.59 | $14.4 | $15.49 | $14.14 |
| Deferred revenue | ||||
| Short long term debt | $18.04 | $18.18 | $18.57 | $19.1 |
| Total current liabilities | $166.74 | $171.69 | $147.4 | $155.77 |
| Long term debt | $4549.86 | $4576.52 | $4623.3 | $4624.19 |
| Total noncurrent liabilities | $5088.82 | $5136.54 | $5220.47 | $5271.2 |
| Total debt | $4567.9 | $4594.7 | $4641.87 | $4643.29 |
| Total liabilities | $5255.56 | $5308.23 | $5367.87 | $5426.97 |
| Shareholders' equity | ||||
| Retained earnings | -$499.31 | -$467.92 | -$443.77 | -$347.59 |
| Other shareholder equity | -$11.78 | $0.38 | ||
| Total shareholder equity | $1709.12 | $1749.59 | $1768.52 | $1788.28 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $81.49 | $340.56 | $188.38 | $126.75 |
| Short term investments | ||||
| Net receivables | $76.56 | $78.91 | $99.91 | $63.2 |
| Inventory | ||||
| Total current assets | $193.59 | $446.74 | $319.26 | $208.85 |
| Long term investments | ||||
| Property, plant & equipment | $287.11 | $257.07 | $243.34 | $218.97 |
| Goodwill & intangible assets | $6462.21 | $6645.4 | $7648.11 | $7841.52 |
| Total noncurrent assets | $6771.09 | $6924.37 | $7901.15 | $8074.72 |
| Total investments | ||||
| Total assets | $6964.69 | $7371.1 | $8220.41 | $8283.58 |
| Current liabilities | ||||
| Accounts payable | $19.59 | $13.29 | $13.01 | $15.26 |
| Deferred revenue | ||||
| Short long term debt | $18.04 | $19.61 | $20.13 | $6.44 |
| Total current liabilities | $166.74 | $175.84 | $141.91 | $112.5 |
| Long term debt | $4549.86 | $4741.86 | $4905.87 | $4605.99 |
| Total noncurrent liabilities | $5088.82 | $5404.72 | $5733.83 | $5613.22 |
| Total debt | $4567.9 | $4782.36 | $4926 | $4612.43 |
| Total liabilities | $5255.56 | $5580.56 | $5875.74 | $5725.71 |
| Shareholders' equity | ||||
| Retained earnings | -$499.31 | -$347.8 | $225.11 | $117 |
| Other shareholder equity | -$11.78 | $0.39 | ||
| Total shareholder equity | $1709.12 | $1790.54 | $2344.67 | $2557.86 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $244.13 | $242.8 | $237.99 | $236.59 |
| Cost of revenue | $60.66 | $60.95 | $59.01 | $54.85 |
| Gross Profit | $183.47 | $181.85 | $178.98 | $181.74 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $36.06 | $36.78 | $39.75 | $31.47 |
| Total operating expenses | $142.66 | $142.34 | $144.28 | $134.8 |
| Operating income | $40.81 | $39.52 | $34.71 | $46.94 |
| Income from continuing operations | ||||
| EBIT | $51.23 | $53.28 | $36.31 | $85.33 |
| Income tax expense | -$0.39 | -$6.88 | -$9.79 | $1.69 |
| Interest expense | $83 | $84.3 | $82.47 | $83.43 |
| Net income | ||||
| Net income | -$31.39 | -$24.14 | -$36.37 | $0.21 |
| Income (for common shares) | -$31.39 | -$24.14 | -$36.37 | $0.21 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $961.52 | $1079.72 | $1117.6 | $937.76 |
| Cost of revenue | $235.47 | $204.1 | $175.29 | $318.68 |
| Gross Profit | $726.06 | $875.62 | $942.31 | $619.09 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $144.06 | $166.84 | $151.09 | $355.63 |
| Total operating expenses | $564.07 | $1238.35 | $556.19 | $750.91 |
| Operating income | $161.98 | -$362.73 | $386.12 | -$131.82 |
| Income from continuing operations | ||||
| EBIT | $226.15 | -$257.34 | $402.93 | -$211.27 |
| Income tax expense | -$15.36 | $12.17 | $33.37 | -$26.34 |
| Interest expense | $333.21 | $303.4 | $267.48 | $335.64 |
| Net income | ||||
| Net income | -$91.7 | -$572.91 | $102.08 | -$520.56 |
| Income (for common shares) | -$91.7 | -$572.91 | $102.08 | -$520.56 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$31.39 | -$24.14 | -$36.37 | $0.21 |
| Operating activities | ||||
| Depreciation | $108.04 | $107.02 | $105.99 | $104.74 |
| Business acquisitions & disposals | $0.35 | -$141.29 | ||
| Stock-based compensation | $4.66 | $4.83 | $4.83 | $3.69 |
| Total cash flows from operations | $27.7 | $72.12 | $7.68 | $64.22 |
| Investing activities | ||||
| Capital expenditures | -$31.34 | -$22.41 | -$31.99 | -$23.1 |
| Investments | ||||
| Total cash flows from investing | -$31.34 | -$22.06 | -$173.29 | -$23.1 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$1.57 | -$7.42 | -$5.72 | |
| Net borrowings | -$20.91 | -$38.33 | -$3.31 | -$103.27 |
| Total cash flows from financing | -$22.48 | -$38.34 | -$10.74 | -$109.44 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$26.12 | $11.72 | -$176.34 | -$68.32 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$91.7 | -$572.91 | $102.08 | -$520.56 |
| Operating activities | ||||
| Depreciation | $425.79 | $415.66 | $412.06 | $403.68 |
| Business acquisitions & disposals | -$140.94 | -$149.43 | -$140.03 | |
| Stock-based compensation | $18.02 | $16.74 | $18.01 | $406.05 |
| Total cash flows from operations | $171.72 | $372.36 | $404.69 | $377.37 |
| Investing activities | ||||
| Capital expenditures | -$108.85 | -$89.73 | -$84.59 | -$70.81 |
| Investments | -$14.71 | $5.64 | ||
| Total cash flows from investing | -$249.79 | -$104.45 | -$228.38 | -$210.84 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$14.71 | -$100 | -$101.12 | |
| Net borrowings | -$165.82 | -$113.28 | -$10.89 | -$642.88 |
| Total cash flows from financing | -$180.99 | -$115.74 | -$114.68 | -$61.6 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$259.06 | $152.18 | $61.62 | $104.93 |
News
Fundamentals
| Market cap | $363.06M |
|---|---|
| Enterprise value | $4.85B |
| Shares outstanding | 648.32M |
| Revenue | $961.52M |
|---|---|
| EBITDA | $651.93M |
| EBIT | $226.15M |
| Net Income | -$91.70M |
| Revenue Q/Q | 1.26% |
| Revenue Y/Y | -10.95% |
| P/E ratio | -3.96 |
|---|---|
| EV/Sales | 5.04 |
| EV/EBITDA | 7.44 |
| EV/EBIT | 21.44 |
| P/S ratio | 0.38 |
| P/B ratio | 0.21 |
| Book/Share | 2.65 |
| Cash/Share | 0.13 |
| EPS | -$0.14 |
|---|---|
| ROA | -1.29% |
| ROE | -5.23% |
| Debt/Equity | 3.08 |
|---|---|
| Net debt/EBITDA | 7.94 |
| Current ratio | 1.16 |
| Quick ratio | 1.16 |